drugset / Trial / NCT06867796
A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults
Phase 1
Not yet recruiting
48 enrolled
TrueLab Biopharmaceutical Co., Ltd
TIGERMED AUSTRALIA PTY LIMITED · collab
RandomizedSequentialDouble-blindTreatment
Summary
The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-001 in healthy adult participants.
Timeline
- Start
- 2025-04
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TL-001 | Unknown | — | Intravenous |
Indications
No indication recorded.